|
Insider Trading: MOLECULAR DEVICES CORP
Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of MOLECULAR DEVICES CORP in the last 24 months are illustrated in figures 1 and 2. Table 1 shows the monthly insider trading data of MOLECULAR DEVICES CORP since year 2005. Table 2 shows the detailed insider transactions of MOLECULAR DEVICES CORP since 2005.
The reporting company's ticker symbol is MDCC.
The reporting company's CIK number is 1003113.
The total value of stock buying since 2005 is $0.
The total value of stock sales is $23,950,854.
The total value of stock exercises is $40,206,684.
1 year stock price chart,
1 day stock price chart
opopp opopopop
Figure 1. Monthly insider transaction values at MOLECULAR DEVICES CORP (MDCC) in the past 24 months.
The trade values of insider stock buys, sales, and option exercises are in logarithmic scale
as shown on the right axis labels.
The detailed monthly and daily insider transactions are listed in the 2 tables below.
08 09 10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 -
Figure 2. Average prices of insider buys, sales, and option exercises at MOLECULAR DEVICES CORP (MDCC) in the past 24 months. See table 2 for insider transaction details.
08 09 10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 -
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises
for MOLECULAR DEVICES CORP (MDCC).
Trading Period
year-month |
Insider Buying
Shares Value ($) |
Insider Sales
Shares Value ($) |
Option Exercises
Shares Value ($) |
| 2007-03 | 0 | 0 | 10,008 | 355,284 | 1,437,385 | 30,561,904 |
| 2007-02 | 0 | 0 | 29,284 | 1,033,928 | 29,284 | 553,111 |
| 2006-05 | 0 | 0 | 25,205 | 738,537 | 20,205 | 299,708 |
| 2006-02 | 0 | 0 | 498,028 | 15,449,101 | 428,681 | 8,791,961 |
| 2005-08 | 0 | 0 | 2,116 | 42,962 | 0 | 0 |
| 2005-05 | 0 | 0 | 342,489 | 6,331,042 | 0 | 0 |
Table 2. Detailed insider stock purchases, sales, and option exercises
for MOLECULAR DEVICES CORP (MDCC)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2007-03-26 | Wicke Robert H (Vice Pres. Product Development) | Option Exercise | 45,135 | 16.53 | 746,081 |
| 2007-03-26 | Hughes Jan (VP Marketing) | Option Exercise | 55,000 | 22.88 | 1,258,583 |
| 2007-03-26 | Davenport Steve (VP European Operations) | Option Exercise | 55,000 | 21.01 | 1,155,550 |
| 2007-03-26 | Keegan Joseph D (CEO/President) | Option Exercise | 391,000 | 21.90 | 8,561,433 |
| 2007-03-26 | Sportsman J Richard (VP Assay & Reagent) | Option Exercise | 45,625 | 21.57 | 984,131 |
| 2007-03-26 | Murray Robert Joseph (VP Operations) | Option Exercise | 265,000 | 21.10 | 5,591,500 |
| 2007-03-26 | Humphries Gillian M K (VP Strategic Affairs) | Option Exercise | 7,500 | 20.49 | 153,675 |
| 2007-03-26 | Sharp Patricia (VP Human Resource) | Option Exercise | 102,000 | 21.57 | 2,200,310 |
| 2007-03-26 | Olenic Thomas J (VP Sales and Service) | Option Exercise | 68,125 | 21.57 | 1,469,456 |
| 2007-03-26 | Harkness Timothy (CFO/VP Finance) | Option Exercise | 115,000 | 21.57 | 2,480,550 |
| 2007-03-26 | Bowman A Blaine (Director) | Option Exercise | 93,000 | 20.55 | 1,911,150 |
| 2007-03-19 | Hughes Jan (VP Marketing) | Option Exercise | 16,000 | 18.64 | 298,160 |
| 2007-03-19 | Waitz J Allan (Director) | Sale | 6,500 | 35.50 | 230,750 |
| 2007-03-19 | Sharp Patricia (VP Human Resource) | Sale | 3,508 | 35.50 | 124,534 |
| 2007-02-28 | Humphries Gillian M K (VP Strategic Affairs) | Sale | 2,536 | 35.32 | 89,571 |
| 2007-02-28 | Humphries Gillian M K (VP Strategic Affairs) | Option Exercise | 2,536 | 21.32 | 54,067 |
| 2007-02-26 | Humphries Gillian M K (VP Strategic Affairs) | Sale | 7,709 | 35.32 | 272,281 |
| 2007-02-26 | Humphries Gillian M K (VP Strategic Affairs) | Option Exercise | 7,709 | 20.49 | 157,957 |
| 2007-02-21 | Humphries Gillian M K (VP Strategic Affairs) | Sale | 9,039 | 35.30 | 319,076 |
| 2007-02-21 | Humphries Gillian M K (VP Strategic Affairs) | Option Exercise | 9,039 | 20.20 | 182,587 |
| 2007-02-20 | Humphries Gillian M K (VP Strategic Affairs) | Sale | 10,000 | 35.30 | 353,000 |
| 2007-02-20 | Humphries Gillian M K (VP Strategic Affairs) | Option Exercise | 10,000 | 15.85 | 158,500 |
| 2006-05-15 | Marion Andre F (Director) | Sale | 16,500 | 28.09 | 463,426 |
| 2006-05-15 | Marion Andre F (Director) | Option Exercise | 16,500 | 14.50 | 239,250 |
| 2006-05-12 | Sportsman J Richard (VP Assay & Reagent) | Sale | 1,450 | 27.96 | 40,534 |
| 2006-05-12 | Sportsman J Richard (VP Assay & Reagent) | Option Exercise | 1,450 | 8.54 | 12,382 |
| 2006-05-08 | Humphries Gillian M K (VP Strategic Affairs) | Sale | 2,255 | 33.00 | 74,415 |
| 2006-05-08 | Humphries Gillian M K (VP Strategic Affairs) | Option Exercise | 2,255 | 21.32 | 48,076 |
| 2006-05-02 | Anderson David L (Director) | Sale | 5,000 | 32.03 | 160,162 |
| 2006-02-28 | Keegan Joseph D (CEO/President) | Sale | 5,000 | 31.82 | 159,105 |
| 2006-02-28 | Keegan Joseph D (CEO/President) | Option Exercise | 5,000 | 19.12 | 95,600 |
| 2006-02-28 | Sharp Patricia (VP Human Resource) | Sale | 10,000 | 31.67 | 316,700 |
| 2006-02-28 | Sharp Patricia (VP Human Resource) | Option Exercise | 10,000 | 19.66 | 196,600 |
| 2006-02-27 | Harkness Timothy (CFO/VP Finance) | Sale | 22,500 | 33.07 | 744,162 |
| 2006-02-27 | Harkness Timothy (CFO/VP Finance) | Option Exercise | 22,500 | 26.62 | 598,950 |
| 2006-02-23 | Olenic Thomas J (VP Sales and Service) | Sale | 12,000 | 33.50 | 402,000 |
| 2006-02-23 | Olenic Thomas J (VP Sales and Service) | Option Exercise | 12,000 | 23.14 | 277,680 |
| 2006-02-22 | Murray Robert Joseph (VP Operations) | Sale | 3,000 | 32.64 | 97,922 |
| 2006-02-22 | Humphries Gillian M K (VP Strategic Affairs) | Sale | 5,665 | 33.08 | 187,369 |
| 2006-02-22 | Humphries Gillian M K (VP Strategic Affairs) | Option Exercise | 5,665 | 20.20 | 114,433 |
| 2006-02-22 | Sharp Patricia (VP Human Resource) | Sale | 30,000 | 32.97 | 989,097 |
| 2006-02-22 | Sharp Patricia (VP Human Resource) | Option Exercise | 30,000 | 21.58 | 647,250 |
| 2006-02-22 | Harkness Timothy (CFO/VP Finance) | Sale | 27,500 | 32.65 | 897,789 |
| 2006-02-22 | Harkness Timothy (CFO/VP Finance) | Option Exercise | 27,500 | 19.97 | 549,083 |
| 2006-02-21 | Keegan Joseph D (CEO/President) | Sale | 34,000 | 32.19 | 1,094,500 |
| 2006-02-21 | Keegan Joseph D (CEO/President) | Option Exercise | 34,000 | 17.48 | 594,490 |
| 2006-02-21 | Harkness Timothy (CFO/VP Finance) | Sale | 40,000 | 32.39 | 1,295,696 |
| 2006-02-21 | Harkness Timothy (CFO/VP Finance) | Option Exercise | 40,000 | 18.02 | 721,000 |
| 2006-02-17 | Keegan Joseph D (CEO/President) | Sale | 26,500 | 31.33 | 830,245 |
| 2006-02-17 | Keegan Joseph D (CEO/President) | Option Exercise | 26,500 | 19.12 | 506,680 |
| 2006-02-17 | Humphries Gillian M K (VP Strategic Affairs) | Sale | 5,000 | 32.51 | 162,550 |
| 2006-02-17 | Humphries Gillian M K (VP Strategic Affairs) | Option Exercise | 5,000 | 20.20 | 101,000 |
| 2006-02-16 | Sportsman J Richard (VP Assay & Reagent) | Sale | 8,900 | 30.84 | 274,476 |
| 2006-02-16 | Sportsman J Richard (VP Assay & Reagent) | Option Exercise | 5,000 | 21.32 | 106,600 |
| 2006-02-16 | Humphries Gillian M K (VP Strategic Affairs) | Sale | 5,000 | 31.38 | 156,920 |
| 2006-02-16 | Humphries Gillian M K (VP Strategic Affairs) | Option Exercise | 5,000 | 20.20 | 101,000 |
| 2006-02-16 | Olenic Thomas J (VP Sales and Service) | Sale | 24,235 | 31.25 | 757,343 |
| 2006-02-16 | Olenic Thomas J (VP Sales and Service) | Option Exercise | 24,235 | 19.67 | 476,621 |
| 2006-02-15 | Keegan Joseph D (CEO/President) | Sale | 5,099 | 30.92 | 157,686 |
| 2006-02-15 | Murray Robert Joseph (VP Operations) | Option Exercise | 3,000 | 13.37 | 40,110 |
| 2006-02-15 | Humphries Gillian M K (VP Strategic Affairs) | Sale | 10,942 | 31.00 | 339,202 |
| 2006-02-15 | Humphries Gillian M K (VP Strategic Affairs) | Option Exercise | 10,942 | 26.62 | 291,276 |
| 2006-02-15 | Anderson David L (Director) | Sale | 16,907 | 30.91 | 522,644 |
| 2006-02-14 | Sportsman J Richard (VP Assay & Reagent) | Sale | 2,345 | 30.54 | 71,606 |
| 2006-02-14 | Sportsman J Richard (VP Assay & Reagent) | Option Exercise | 2,345 | 17.76 | 41,635 |
| 2006-02-14 | Humphries Gillian M K (VP Strategic Affairs) | Sale | 14,058 | 30.31 | 426,150 |
| 2006-02-14 | Humphries Gillian M K (VP Strategic Affairs) | Option Exercise | 14,058 | 26.62 | 374,223 |
| 2006-02-13 | Keegan Joseph D (CEO/President) | Sale | 5,404 | 28.72 | 155,175 |
| 2006-02-13 | Mcconnell Harden M (Director) | Sale | 14,919 | 29.05 | 433,396 |
| 2006-02-13 | Sportsman J Richard (VP Assay & Reagent) | Sale | 7,980 | 29.00 | 231,420 |
| 2006-02-13 | Sportsman J Richard (VP Assay & Reagent) | Option Exercise | 7,980 | 21.58 | 172,168 |
| 2006-02-10 | Davenport Steve (VP European Operations) | Sale | 15,000 | 28.92 | 433,837 |
| 2006-02-10 | Davenport Steve (VP European Operations) | Option Exercise | 15,000 | 18.77 | 281,550 |
| 2006-02-10 | Keegan Joseph D (CEO/President) | Sale | 10,000 | 28.90 | 288,980 |
| 2006-02-10 | Mcconnell Harden M (Director) | Sale | 5,018 | 29.01 | 145,572 |
| 2006-02-10 | Sportsman J Richard (VP Assay & Reagent) | Sale | 17,000 | 29.01 | 493,127 |
| 2006-02-10 | Sportsman J Richard (VP Assay & Reagent) | Option Exercise | 17,000 | 17.86 | 308,878 |
| 2006-02-10 | Harkness Timothy (CFO/VP Finance) | Sale | 50,000 | 28.95 | 1,447,500 |
| 2006-02-10 | Harkness Timothy (CFO/VP Finance) | Option Exercise | 50,000 | 19.85 | 998,700 |
| 2006-02-09 | Sportsman J Richard (VP Assay & Reagent) | Sale | 3,000 | 30.81 | 92,430 |
| 2006-02-01 | Hughes Jan (VP Marketing) | Sale | 1,200 | 28.90 | 34,680 |
| 2005-08-29 | Davenport Steve (VP European Operations) | Sale | 433 | 21.28 | 9,213 |
| 2005-08-19 | Finkel Alan (CTO/Sr Vice Presiden) | Sale | 1,683 | 20.05 | 33,749 |
| 2005-05-31 | Sportsman J Richard (Reagent) | Sale | 444 | 19.20 | 8,524 |
| 2005-05-26 | Bowman A Blaine (Director) | Sale | 48,150 | 19.00 | 914,850 |
| 2005-05-05 | Finkel Alan (CTO/Sr Vice Presiden) | Sale | 293,895 | 18.40 | 5,407,668 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of MOLECULAR DEVICES CORP (symbol MDCC,
CIK number 1003113) see
the Securities and Exchange Commission (SEC) website.
|
|
